Pharmacokinetic/pharmacodynamic properties of eculizumab support established efficacy in patients with NMOSD: findings from the phase 3 PREVENT study
Achim Berthele, Celia Oreja‐Guevara, Jacqueline Palace, Dean M. Wingerchuk et autres
3 citationsmediaTUM (Technical University of Munich)